Shrikrishna Upadhyaya 13/02/2023 Shrikrishna Upadhyaya 13/02/2023

Takshashila Working Paper - Biotechnology and Geopolitics

By Shambhavi Naik

Saurabh Todi 09/02/2023 Saurabh Todi 09/02/2023

Takshashila Discussion Document - Gene Drives and Vector-Borne Diseases: A Comparative Perspective Using Malaria as a Case Study

By Saurabh Todi

Guest User 01/02/2023 Guest User 01/02/2023

Takshashila Blue Paper: Re-energising India’s Biotech Ecosystem

By Shambhavi Naik

Guest User 09/01/2023 Guest User 09/01/2023

Views on Heritable Gene Editing: Survey from India

By Shambhavi Naik

Guest User 06/01/2023 Guest User 06/01/2023

ORF Issue Brief - Reevaluating Bioweapons Amid Global Political Fragility

By Shambhavi Naik

Shrikrishna Upadhyaya 18/11/2022 Shrikrishna Upadhyaya 18/11/2022

ORF & Global Policy Journal Article - Gene Editing and the Need to Reevaluate Bioweapons

By Shambhavi Naik

Shrikrishna Upadhyaya 14/11/2022 Shrikrishna Upadhyaya 14/11/2022

Takshashila Issue Brief - GM Mustard Offers a Chance to Relook at India’s Gene Editing Governance

By Shrikrishna Upadhyaya

Guest User 11/11/2022 Guest User 11/11/2022

Takshashila Discussion SlideDoc - A New Approach to Nutrition in Karnataka

By Harshit Kukreja and Shambhavi Naik

Shrikrishna Upadhyaya 03/10/2022 Shrikrishna Upadhyaya 03/10/2022

Takshashila Issue Brief - Biotechnology Initiative for India

By Shrikrishna Upadhyaya

Guest User 22/08/2022 Guest User 22/08/2022

Takshashila Policy Advisory - Comments on the Draft Drugs, Medical Devices And Cosmetics Bill, 2022

By Harshit Kukreja and Shambhavi Naik

Guest User 05/07/2022 Guest User 05/07/2022

Takshashila Discussion Document - Nutritional Outcomes in Karnataka: Analysis and Recommendations

By Harshit Kukreja and Shambhavi Naik

Guest User 27/01/2022 Guest User 27/01/2022

Takshashila Issue Paper - The Case for Quad Co-operation in Biotechnology

By Arjun Gargeyas, Ruturaj Gowaikar and Shambhavi Naik

Aditya Ramanathan 14/01/2022 Aditya Ramanathan 14/01/2022

IPPR Journal Article - The New Bioweapons Peril

By Shambhavi Naik and Aditya Ramanathan

Harshit Kukreja 07/12/2021 Harshit Kukreja 07/12/2021

Takshashila Issue Paper - Tackling New COVID-19 Variants

By Harshit Kukreja, Priyal Lyncia D’Almeida, Ruturaj Gowaikar and Shambhavi Naik

15/09/2021 15/09/2021

Takshashila Issue Paper - Biobanking Policies in India

By Sunila Dixit, Priyal Lyncia D’Almeida, Manjulika Vaz and Shambhavi Naik

19/08/2021 19/08/2021

Takshashila Discussion Document - A National Epidemic Intelligence Service for India

By Ruturaj Gowaikar and Shambhavi Naik

17/11/2020 17/11/2020

Takshashila Discussion SlideDoc - A Strategy to make India a Biotech Leader by 2025

By Shambhavi Naik

06/11/2020 06/11/2020

Takshashila Discussion Document - Analysis of COVID-19 Serosurveys in India

By Sunila Dixit and Shambhavi Naik

05/11/2020 05/11/2020

IPPR Journal Article - A COVID-19 Vaccine Deployment Strategy for India

By Shambhavi Naik, Ameya Paleja, Mihir Mahajan, Narayan Ramachandran, Sunila Dixit, Rahul Matthan, Nitin Pai and Pranay Kotasthane

01/10/2020 01/10/2020

Takshashila Discussion Document - Ethical Guidelines for Clinical Trials and Research in India

By Sunila Dixit